Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Economic information and modeling report Budget impact model

Approach and framework

1 evidence topic · 1 source

Irish submission: budget model

“budget impact analysis” (opens the source at this quote in a new tab)